Q1FY21 results: Dabur India net profit shrinks by 5.87 per cent YoY to Rs 341.8 crore
Dabur India Ltd., one of the best Ayurvedic & Natural Health Care Company announced its quarterly results on July 30, 2020. The company posted a consolidated net profit of Rs 341.8 crore for Q1FY21, which declined by 5.87 per cent, as compared to Q1FY20 when it reported Rs 363.1 crore.
The consolidated net sales reported in Q1FY21 came in at Rs 1,980 crore, which declined by 12.9 per cent YoY from Rs 2,273.3 crore in Q1FY20. At EBITDA level, the company stood at Rs 488.4 crore in Q1FY21 that decreased by 8.01 per cent YoY. For Q1FY20, it posted an EBITDA of Rs 530.9 crore.
EBITDA margin as of Q1FY21 was at 24.67 per cent that increased by 1.32 per cent YoY. The net profit margin in Q1FY21 came in at 17.26 per cent, which increased by 1.29 per cent YoY. The net profit margin in Q1FY20 was at 15.97 per cent.
Amidst the lockdown due to COVID-19, the quarter saw a nearly 7-fold growth in demand for Dabur Chyawanprash and an over 60 per cent surge in demand for Dabur Honey. The company also introduced new variants based on consumer needs for health, immunity and hygiene, which resulted in sales of over Rs 100 crore in this quarter.
The share of the company closed with gains of 0.55 per cent at Rs 492.6. It has a 52 week high of Rs 525.3 and 52 week low of Rs 385.05 on BSE.
Particulars
|
Q1FY21
(Rs in cr)
|
Q1FY20
(Rs in cr)
|
per cent
change
|
Net Profit
|
341.80
|
363.10
|
-5.87
|
Net Revenue
|
1,980.00
|
2,273.30
|
-12.90
|
Operating Profit
|
488.40
|
530.90
|
-8.01
|
EBITDAM(per cent)
|
24.67
|
23.35
|
1.32
|
PATM(per cent)
|
17.26
|
15.97
|
1.29
|